Embecta Corp. was incorporated in Delaware on July 8, 2021. The company is a leading global medical device company focused on providing solutions to improve the health and well-being of people with diabetes. On a century-old basis, the company believes that its products have become one of the most widely recognized and respected brands in the field of diabetes management in the world. The company estimates that its products are used by more than 30 million people in more than 100 countries for the daily management of insulin and diabetes. The company has a broad portfolio of marketed products, including a variety of pen needles, syringes and safety devices, supplemented by proprietary digital applications designed to help people manage diabetes. 

Expected P&L on Expiry

Key Stats

Pricing Model

About EMBC20260918C5